The sovereign British state of Gibraltar has legalized non-smokable medical cannabis use for muscle spasticity and multiple sclerosis, severe epilepsy, “life-altering” pain, and vomiting and nausea associated with chemotherapy, according to a Vox Gibraltar report. The products will be supplied through the Gibraltar Health Authority, though it’s unclear whether they will be cultivated locally or imported.
Acting Medical Director Dr. Krishna Rawal called the reforms “a milestone” for healthcare in Gibraltar which required “extensive research and consultation.” Physicians who want to authorize medical marijuana use must undergo GHA training.
“I am extremely keen to always provide patients with as many options as possible for their medical treatment, recovery, and their return to good health and wellbeing. In my considered view, cannabis oil certainly has its place in the modern medical care of some patients. Over time, I am certain that the increased use of cannabis for medical purposes will generate overwhelming evidence in support of its use.” – Rawal, to Vox
Medical marijuana distribution will be limited to just one GHA pharmacy at St. Bernard’s Hospital. According to the report, the government is open to adding qualifying conditions, adding that the current list “have the weight of evidence to support the success of cannabis as part of an overall treatment regime.”
The United Kingdom legalized medical cannabis on a very limited basis in 2018.
Get daily cannabis business news updates. Subscribe